In line with this, reduced numbers of CD39+FOXP3+ Tregs were observed in patients affected by multiple sclerosis (MS), indicating that CD39 expression in Tregs is critical in controlling inflammatory autoimmune disorders [24]. Here, ENTPD1 is linked to myeloid sarcoma.